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RNA Helicase A Mediates Association of CBP
with RNA Polymerase II
Toshihiro Nakajima,* Chiharu Uchida,* kinase inducible domain (KID) modulates CREB activity
via a phospho(Ser-133)-dependent association with theStephen F. Anderson,² Chee-Gun Lee,³
Jerard Hurwitz,³ Jeffrey D. Parvin,² coactivators CBP and P300 (Parker et al., 1996; Naka-
jima et al., 1997).Marc Montminy*§‖
*Department of Cell Biology In addition to mediating transcriptional induction via
CREB, CBP/P300 have also been shown to function as²Department of Pathology
Harvard Medical School coactivators for a number of signal-dependent factors
including c-Jun (Arias et al., 1994), SAP 1A (Janknecht²Division of Molecular Oncology
Brigham and Women's Hospital and Nordheim, 1996), STAT-2 (Bhattacharya et al.,1996),
and certain members of the nuclear hormone receptorBoston, Massachusetts 02115
³Program in Molecular Biology superfamily (Chakravarti et al., 1996; Kamei et al., 1996).
The general importance of CBP/P300 in nuclear signal-Memorial Sloan-Kettering Cancer Center
New York, New York 10021-6007 ing has been reinforced by recent findings that some
pathways may interfere with one another by competing
for recruitment of these coactivators (Kamei et al., 1996;
Nakajima et al., 1996).Summary
CBP/P300 have been proposed to mediate transcrip-
tional induction via intrinsic (Bannister and Kouzarides,The coactivator CBP has been proposed to stimulate
1996; Ogryzko et al., 1996) and associated (Yang et al.,the expression of certain signal-dependent genes via
1996) histone-acetylase activities, which may facilitateits association with RNA polymerase II complexes.
binding of nuclear factors to their target sites by destabi-Here we show that complex formation between CBP
lizing promoter-bound nucleosomes. Indeed, changesand RNA polymerase II requires RNA helicase A (RHA),
in promoter occupancy following growth factor/hor-a nuclear DNA/RNA helicase that is related to the Dro-
mone addition have been noted for a number of signal-sophila male dosage compensation factor mle. In tran-
dependent factors, such as the STAT proteins (Mirko-sient transfection assays, RHA was found to cooperate
vitch et al., 1992). But for other proteins, including CREB,with CBP in mediating target gene activation via the
promoter occupancy appears tobe constitutive (HerreraCAMP responsive factor CREB. As a mutation in RHA
et al., 1989; Nichols et al., 1992), suggesting that, inthat compromised its helicase activity correspond-
certain cases, histone-acetylase activities may not beingly reduced CREB-dependent transcription, we pro-
required for transcriptional induction via signal-depen-pose that RHA may induce local changes in chromatin
dent activators.structure that promote engagement of the transcrip-
In addition to their role as chromatin-remodeling fac-tional apparatus on signal responsive promoters.
tors, CBP/P300 have also been proposed to mediate
target gene activation through a direct association withIntroduction
specific general transcription factors (Kwok et al., 1994;
Kee et al., 1996). In a recent series of biochemical stud-A number of hormones and growth factors appear to
ies, for example, we found that CBP was associatedinduce the expression of certain genes by stimulating
with functional RNA polymerase II complexes that werethe phosphorylation of specific nuclear factors. The sec-
capable of stimulating transcription via phospho(Ser-ond messenger cAMP, for example, stimulates the tran-
133) CREB in vitro (Nakajima et al., 1997). CBP/P300scription of numerous genes via the PK-A±mediated
associate with RNA polymerase II via a Cys/His±richphosphorylation of the cAMP responsive factor CREB
region, termed C/H3, which is also recognized by theat Ser-133 (Gonzalez and Montminy, 1989). Although
Adenovirus E1A oncoprotein and the mitogen-activatedphosphorylation has been shown to stimulate a number
pp90RSK (Eckner et al., 1994; Nakajima et al., 1996).of nuclear factors via their DNA-binding or nuclear-tar-
CBP/P300 do not copurify with RNA polymerase IIgeting activities, CREB belongs to a group of activators
in vitro. And we have been unable to detect a directwhose transactivation potential is specifically affected
association between CBP and any of the RNA polymer-(Gonzalez and Montminy, 1989; Hagiwara et al., 1992).
ase II subunits, prompting us to screen for a bridgingThe CREB transactivation domain is bipartite, con-
factor that mediates the CBP±RNA polymerase II (pol II)sisting of constitutive and inducible activators, termed
interaction. Here we characterize cDNAs for this bridg-Q2 and KID, respectively, which function synergistically
ing factor and evaluate its importance for target genein response to cAMP (Brindle et al., 1993; Quinn, 1993).
induction via phospho(Ser-133) CREB in vivo.The glutamine-rich Q2 domain has been shown to en-
gage the transcriptional apparatus via a constitutive in-
teraction with the TBP-associated factor hTAFII130 (Fer- Results
reri et al., 1994; Nakajima et al., 1997). By contrast, the
Previous results demonstrating that the C/H3 region (aa
1805±1890) of CBP associates with pol II complexes via§To whom correspondence should be addressed.
an intermediary factor (Nakajima et al., 1997) prompted‖ Present address: Joslin Diabetes Center, Boston, Massachusetts
02215. us to screen a lgt11 human placental cDNA bacterial
Cell
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Figure 2. RHA Binds to RNA Polymerase II In Vitro
Western blot (right) assay of RNA polymerase II using anti-CTD
antiserum against the 200 kDa subunit of pol II. Figure shows pol II
recovered from GST-RHA resins following coincubation with purified
calf thymus±core RNA polymerase II. Amino acid endpoints for RHA
fragments used in individual reactions indicated over each lane.
1±250) containing the N-terminal basic region was capa-
ble of binding efficiently to the C/H3 region of CBP
(Figure 1, top). Reciprocal interaction assays performed
with GST-CBP polypeptides revealed that the C/H3 re-
gion (aa 1805±1890) alone was capable of binding to
full-length RHA in vitro (Figure 1, bottom).
Basedon the hypothesis that RHA functions as a CBP-
pol II±bridging factor, we investigated whether RHA can
bind directly to purified pol II in vitro. Following incuba-
tion with purified calf thymus pol II, GST-RHA polypep-
tide resins were washed and evaluated by Western blot
Figure 1. RHA Binds to CBP In Vitro analysis with C-terminal domain antiserum against the
(Top) GST pull-down assay of 35S-labeled CBP C/H3 peptide (aa 200 kDaa subunit of pol II. Only one RHA fragment (RHA
1805±1890) using GST (GST) or GST-RHA resins. Amino acid end- 230±650) was found to interact detectably with pol II in
points for each RHA construct are indicated over each lane. INPUT, vitro (Figure 2). These results indicate that RHA is capa-
20% of input CBP fragment shown. Above, schematic showing rela-
ble of binding directly to both CBP and pol II, and thattive position of individual domains of RHA, including N-terminal
different regions of RHA are required for interaction withbasic region, central core helicase domain with DEAH consensus,
each protein.and C-terminal RGG motif. Amino acid number shown below sche-
matic. (Bottom) GST pull-down assay of full-length (aa 1±1279) 35S- To test the prediction that RHA can mediate complex
labeled RHA using GST-CBP polypeptide resins. Amino acid end- formation between CBP and pol II via direct contacts
points for each GST-CBP construct shown over the corresponding with each protein, we performed GST pull-down and
lane. GST, control assay with GST resin alone. INPUT, 50% of total in vitro transcription assays. When fused to GST and
35S-labeled RHA added to each resin. Arrow points to full-length
immobilized on glutathione sepharose beads, the C/H3RHA protein. Above, schematic of CBP with individual domains
region of CBP alone was unable to bind directly to puri-indicated: NR, nuclear receptor binding region (aa 1±120); CREB,
fied pol II in vitro (Figure 3). Following addition of purifiedCREB binding domain (aa 591±680); HAT, histone acetyl transferase
(HAT) catalytic domain; pol II, RNA polymerase II binding region (aa full-length RHA protein, however, GST-C/H3 resin (Fig-
1805±1890). ure 3) but not GST resin alone (not shown) was found
to associate with pol II, both by Western blot (Figure 3,
top) and in vitro transcription (Figure 3, bottom) assay.
expression library for cDNAs encoding the putative Addition of an N-terminal RHA competitor peptideÐ
CBP-pol II±bridging protein. Using a biotinylated C/H3 containing the CBP-binding domain of RHAÐblocked
peptide probe, we identified two CBP1805±1890 interacting the association of pol II with the C/H3 domain, revealing
clones out of 3 3 106 plaques. Both cDNA clones were the importanceof full-length RHA for CBP-pol II complex
found to encode RNA helicase A (RHA), a 140 kDa nu- formation (Figure 3).
clear 39-59 double-stranded DNA/RNA helicase (Lee and To determine whether CBP±RHA complexes are de-
Hurwitz, 1993). Of other helicase family members that tectable in vivo, we performed coimmunoprecipitation
contain a consensus DEAH box motif, RHA is most studies on nuclear lysates from 293T cells. About 20%
closely related to human nuclear DNA helicase II (90% of cellular CBP was recovered from immunoprecipitates
identity; Zhang et al., 1995) and to Drosophila MLE (50% of RHA by Western blot assay with anti-CBP antiserum
identity), a protein required for X chromosome dosage (Figure 4, top panel; compare lanes 3 and 4). A similar
compensation in males (Kuroda et al., 1991). RHA con- fraction of endogenous RHA was recovered from immu-
tains three identifiable domains: an N-terminal basic re- noprecipitates of CBP but not from preimmune serum
gion, a centrally located catalytic core with consensus (Figure 4, middle panel; compare lanes 3 and 4), indicat-
DEAH motif, and a C-terminal glycine-rich region with ingthat RHA is indeed associated with CBP atsignificant
canonical RGG motif that is capable of binding single- levels in vivo. About 10%±20% of total pol II was de-
stranded nucleic acids (Lee and Hurwitz, 1993). Using tected in immunoprecipitates of RHA (Figure 4, bottom;
a series of RHA polypeptides fused to glutathione compare lanes 3 and 4), suggesting that cellular RHA is
indeed associated with both CBP and pol II.S-transferase (GST), we found that one fragment (RHA
CBP Associates with pol II via RNA Helicase A
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Figure 3. RHA Mediates Association of CBP with RNA Poly-
merase II
(Top) Western blot assay of RNA polymerase II recovered from GST-
CBP1805±1890 resin following interaction assay with full-length baculo-
virus expressed RHA (RHA), purified calf thymus±RNA polymerase
II (Pol II ), and N-terminal CBP-binding domain of RHA (N-RHA) as Figure 4. RHA Associates with CBP and RNA Polymerase II In Vivo
indicated. Western blot assay was performed with anti-CTD antise-
Western blot analysis of CBP (top) RHA (middle), orRNA polymerase
rum. Input levels of RNA polymerase II from calf thymus RNA poly-
II (bottom) recovered from immunoprecipitates of 293T whole cell
merase II fraction shown. Purified RHA contained no detectable extracts using preimmune (PI), anti-CBP (aCBP), anti-CTD (aCTD),
RNA polymerase II protein by Western blot assay. or anti-RHA antisera (aRHA). In each case, 20% of input extract
(Bottom) In vitro transcription assay of GST-CBP1805±1890 beads fol- (INPUT) shown.
lowing interaction assays with RHA and RNA polymerase II. Tran-
scription assays were performed using all purified general transcrip-
tion factors except RNA polymerase II, which was supplied by the cells. When cotransfected together, RHA and CBP vec-
GST resin. Activity derived from MLP template shown. tors induced reporter activity16-fold in PK-A±stimulated
but not quiescent cells, demonstrating that these pro-
teins function synergistically in response tocAMP stimu-The ability of RHA to associate with CBP and pol II in
vivo prompted us to evaluate the importance of this hel- lation (Figure 5). RHA and CBP had no effect on transacti-
vation via a mutant GAL4-CREBM1 vector containingicase for transcriptional induction via CREB. In transient
assays of 293T cells, PK-A induced CRE-CAT reporter a Ser-133/Ala-133 substitution at the PK-A phospho-
acceptor site, however, revealing that target gene induc-activity 8-fold, and transfection of either full-length RHA
or CBP constructs further enhanced CRE-CAT activity tion by RHA and CBP is indeed phospho(Ser-133)-
dependent (Figure 5).2-fold (Figure 5). Remarkably, cotransfection of RHA
plus CBP expression vectors induced reporter activity To determine whether RHA may promote activation
of cAMP-responsive genes in part via its helicase activ-20-fold in PK-A±stimulated cells, demonstrating the
ability of these proteins to function cooperatively on ity, we constructed a mutant RHA cDNA, referred to as
mtRHA, which contains a Lys-417 to Arg-417 substitu-cAMP-responsive promoters. By contrast, a truncated
RHA polypeptide (N-RHA) containing only the CBP bind- tion in the ATP-binding site of RHA. Although wild-type
RHA and mutant mtRHA constructs were expressed ating domain (aa 1±250) blocked PK-A induction of the
CRE-CAT reporter about 3-fold, revealing the impor- comparable levels in transfected cells (data not shown),
the mtRHA protein was less active than wild-type RHAtance of full-length RHA for transcriptional activation.
To assess the regulatory effects of RHA and CBP on (Figure 5), supporting the notion that RHA helicase activ-
ity contributes to the activation of cAMP responsiveCREB activity per se, we performed transfection assays
with a GAL4 CREB expression vector containing the genes by phospho(Ser-133) CREB.
GAL4 DNA±binding domain (aa 1±147) fused to the
transactivation domain (aa 1±283)of CREB. GAL4-CREB Discussion
activity, evaluated by cotransfection with a G5B CAT
reporter containing five GAL4 recognition sites, was in- Like other signaling pathways, cAMP has been shown
to regulate gene expression in three distinct phases:creased 5-fold in response to PK-A induction (Figure
5). Overexpression of CBP or RHA further potentiated burst, attenuation, and recovery (Montminy, 1997). The
burst phase, during which peak levels of cellular geneGAL4-CREB activity 2- to 5-fold in PK-A±stimulated
Cell
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Figure 5. RHA Promotes Activation of cAMP
Responsive Genes via phospho(Ser-133)
CREB and CBP
Transient assays of 293T cells using CRE-
CAT reporter (left), GAL4-CREB plus G5B
CAT reporter containing 5 GAL4 recognition
sites (center), or Ser/Ala 133 phosphoryla-
tion-defective mutant GAL4-CREBM1 plus
G5B CAT reporter (right). Activity shown as
percent 14C-chloramphenicol converted to
acetylated forms after normalizing for trans-
fection efficiency via cotransfected RSV-
bGAL plasmid. Reporter activity was induced
by cotransfection of wild-type (PK-A) or cata-
lytically inactive (CON) PK-A expression vec-
tor, which contains a Lys/Met72 substitution
in the ATP-binding site. Cells cotransfected
with various expression vectors indicated be-
low each set of bars. CMV, control CMV ex-
pression plasmid minus insert. Wild-type
CBP and RHA constructs indicated. mtRHA,
mutant RHA expression vector containing
K/R 417 substitution in the ATP-binding domain that abolishes RHA helicase activity in vitro; N-RHA, expression vector containing N-terminal
CBP-binding domain of RHA (1±250). Equivalent expression of RHA, N-RHA, mtRHA, CBP, and GAL4 CREB constructs under all conditions
was confirmed by Western blotting (not shown).
transcription are observed, occurs within 30 min of in- is particularly attractive in view of the rapid reversibility
duction by cAMP and is rate limited by nuclear entry of of the transcriptional response following cessation of
PK-A catalytic subunit. About 40%of total CREB protein the cAMP stimulus (Montminy, 1997).
is Ser-133 phosphorylated in response to a maximal RHA is highly homologous to Drosophila maleless
stimulus, and submaximal signals induce proportion- (MLE), whose gene product is required for dosage com-
ately lower levels of Ser-133 phosphorylation as well as pensation onthe male Xchromosome (Bone et al., 1994).
target gene expression. Mle protein has been observed cytologically along the
Over the next 4±6 hr, CREB phosphorylation and X chromosome as well as at a number of autosomal
cAMP responsive gene transcription attenuate to near locations. And mle appears to colocalize with (Lys-16)
basal levels, owing to the PP-1±mediated dephosphory- acetylated histone H4 in immunocytochemical experi-
lation of CREB at Ser-133 (Hagiwara et al., 1992). Re- ments, suggesting that a histone acetylase may associ-
markably, addition of PP-1 antagonists such as okadaic ate with mle and activate appropriate genes (Bone et
acid and Inhibitor-1 protein can reverse the attenuation al., 1994). In preliminary studies with Schneider SL2
phase and maintain peak levels of target gene expres- cells, we have observed that mle associates with a 250
sion. The CBP-pol II recruitment mechanism we propose kDa CBP immunoreactive protein which contains his-
may explain why the kinetics of target gene expression tone acetylase activity (T. N. and M. M., unpublished
during the burst and attenuation phases are so inti- data). It is tempting to speculate that, as with RHA,
mately connected to Ser-133 phosphorylation: Ser-133 mle may induce target gene expression in part via its
phosphorylation induces transcription via the recruit- association with a Drosophila homolog of CBP.
ment of CBP-pol II complexes, and the subsequent de-
phosphorylation of CREB would release CBP, thereby
Experimental Procedures
disengaging pol II from the promoter.
The interaction of CBP with pol II in vitro requires Interaction and In Vitro Transcription Assays
RHA, which is shown here to bind directly to both CBP For interaction assays in Figure 3, 100 ng calf thymus±core RNA
polymerase was incubated with 2 mg GST CBP1805±1890 plus, whereand pol II in vivo. These results are further supported by
indicated, full-length baculovirus-expressed RHA protein (100 ng)biochemical studies in which RHA was found to copurify
and N-RHA peptide fragment (20 mg) containing CBP binding do-with functional CBP-pol II complexes from Hela cell ex-
main of RHA. Following coincubation on ice for 30 min, glutathionetracts (T. N. and M. M., unpublished data). RHA binds
sepharose±bound complexes were washed and analyzed by in vitro
to the C/H3 domain of CBP, a region that is also recog- transcription and Western blot assays.
nized by the Adenovirus E1A oncoprotein and the mito- In vitro transcription assays were performed on GST-CBP beads,
gen-activated pp90RSK (Eckner et al., 1994; Nakajima et following pull-down assay with RHA and RNA polymerase II as re-
ported (Nakajima et al., 1997), using an MLP template fused to a 210-al., 1996). In view of their inhibitory effects on CBP activ-
nucleotide G-less cassette. Functional RNA polymerase II activityity in vivo, E1A and pp90RSK may block target gene induc-
associated with GST-CBP beads was evaluated in reactions con-tion in part by competing with RHA for binding to CBP.
taining all purified general transcription factors except RNA poly-The involvement of a DNA helicase such as RHA in
merase II, which was supplied by the GST CBP beads (Nakajima etsignal-dependent transcription is intriguing because it
al., 1997).
suggests that recruitment of CBP complexes may pro-
mote local unwinding of promoter DNA via RHA and Plasmids and Antisera
thereby permit engagement of the transcriptional appa- Pinpoint CBP vector was prepared by inserting CBP cDNA fragment
ratus. The proposed ability of RHA to cause local chro- encoding aa 1805±1890 in-frame into pinpoint Xa-1 vector (Pro-
mega). The pinpoint CBP fusion protein containing an N-terminalmatin changes without attendant histone modification
CBP Associates with pol II via RNA Helicase A
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biotinylation tag was purified on avidin-sepharose beads and eluted D'Andrea, A., and Livingston, D. (1996). Cooperation of STAT2 and
P300/CBP insignaling induced by interferon-a. Nature 383, 343±347.with free biotin as recommended by the manufacturer. RHA antise-
rum was raised against baculovirus-expressed RHA protein. N-RHA Bone, J., Lavender, J., Richman, R., Palmer, M., Turner, B., and
expression vector was constructed by inserting the RHA cDNA frag- Kuroda, M. (1994). Acetylated histoneH4 on the male X chromosome
ment (aa 1±88) in-frame into the CS21 expression vector (gift of H. is associated with dosage compensation in Drosophila. Genes Dev.
Weintraub) containing a nuclear localization sequence and myc tag. 8, 96±104.
Brindle, P., Linke, S., and Montminy, M. (1993). Analysis of a PK-A
Far Western Blot and Expression Cloning dependent activator in CREB reveals a new role for the CREM family
For expression cloning, a human placental cDNA library (Stratagene) of repressors. Nature 364, 821±824.
was screened according to the manufacturer's protocol. Recombi-
Chakravarti, D., LaMorte, V., Nelson, M., Nakajima, T., Schuylman,
nant plaques were allowed to grow at 378C for 4 hr and then induced
I., Juguilon, H., Montminy, M., and Evans, R. (1996). Role of CBP/
with 1 mM IPTG-impregnated nitrocellulose filters for 3.5 hr. Filters
P300 in nuclear receptor signaling. Nature 383, 99±103.
were then denatured in 6 M guanidinium hydrochloride, 50 mM Tris
Eckner, R., Ewen, M.E., Newsome, D., Gerdes, M., DeCaprio, J.A.,(pH 8.0), 5 mM b-mercaptoethanol, 0.05% Tween 20 for 1 hr at room
Lawrence, J.B., and Livingston, D.M. (1994). Molecular cloning andtemperature. Immobilized proteins were renatured overnight at 48C
functional analysis of the adenovirus E1A-associated 300-kDa pro-in 50 mM Tris (pH 8.0), 5 mM b-mercaptoethanol, 0.05% Tween 20.
tein (p300) reveals a protein with properties of a transcriptionalFilters were then placed in blocking buffer containing 5% nonfat
adaptor. Genes Dev. 8, 869±884.dry milk, 1% BSA, 0.1% Triton X-100, 13 phosphate buffered saline
Ferreri, K., Gill, G., and Montminy, M. (1994). The cAMP regulated(PBS) for 1 hr at room temperature. Membranes were rinsed in buffer
transcription factor CREB interacts with a component of the TFIIDA (10 mM Tris Acetate [pH 7.5], 100 mM potassium acetate, 5 mM
complex. Proc. Natl. Acad. Sci. USA 91, 1210±1213.MgCl2, 1 mM DTT, 0.5% BSA, 0.5% nonfat dry milk, 0.1% Triton
X-100, 1 mM EDTA, 5% glycerol) and incubated with pinpoint CBP Gonzalez, G.A., and Montminy, M.R. (1989). Cyclic AMP stimulates
probe (0.1 mg/ml) in buffer A for 4 hr at room temperature. Filters somatostatin gene transcription by phosphorylation of CREB at Ser-
were washed, and hybridization products were detected using con- ine 133. Cell 59, 675±680.
jugated streptavidin-alkaline phosphatase. Hagiwara, M., Alberts, A., Brindle, P., Meinkoth, J., Feramisco, J.,
Deng, T., Karin, M., Shenolikar, S., and Montminy, M. (1992). Tran-
Transient Transfection Assays scriptional attenuation following cAMP induction requires PP-1±
Transfection assays were performed in 293T cells as previously mediated dephosphorylation of CREB. Cell 70, 105±113.
described (Brindle et al., 1993). In all assays, CAT activity derived Herrera, R., Shaw, P., and Nordheim, A. (1989). Occupation of the
from CRE-CAT and G5B-CAT reporter plasmids was determined c-fos serum response element in vivo by a multiprotein complex is
after normalizing to b-galactosidase activity from cotransfected unaltered by growth factor induction. Nature 340, 68±70.
RSV-bgal control plasmid. All experiments were performed in tripli-
Janknecht, R., and Nordheim, A. (1996). Regulation of the c-foscate. Equivalent expression of RHA, CBP, and GAL4-CREB con-
promoter by the ternary complex factor Sap-1a and its coactivatorstructs under different conditions was verified by Western blot
CBP. Oncogene 12, 1961±1969.assay.
Kamei, Y., Xu, L., Heinzel, T., Torchia, J., Purokawa, R., Gloss, B.,293T cells were transfected with 500 ng CRE-CAT reporter, 20 ng
Lin, S., Heyman, R., Rose, D., Glass, C., and Rosenfeld, M.G. (1996).RSV-bgal control plasmid, 0.1 mg PK-A vector (wild-type and mu-
A CBP integrator complex mediates transcriptional acativation andtant), plus 0.5 mg each of RHA and/or CBP expression plasmid. The
AP-1 inhibition by nuclear receptors. Cell 85, 403±414.total level of expression vector was kept constant (2 mg) by including
empty CMV expression plasmid. Kee, B., Arias, J., and Montminy, M. (1996). Adaptor mediated re-
For assays with GAL-4 CREB expression vectors, 293T cells were cruitment of RNA polymerase II to a signal-dependent activator. J.
transfected with 0.5 mg G5B-CAT reporter containing 5 GAL4 recog- Biol. Chem. 271, 2373±2375.
nition sites, 20 ng RSV-bgal control plasmid, 0.5 mg wild-type or Kuroda, M., Kernan, M., Kreber, R., Ganetzky, B., and Baker, B.
Ser/Ala-133 mutant GAL4 CREB1±283, 0.1 mg PK-A vector, plus 0.5 (1991). The maleless protein associates with the X chromosome to
mg RHA and/or CBP effector plasmid. Total level of effector plasmid regulate dosage compensation in Drosophila. Cell 66, 935±947.
was kept constant by balancing with empty CMV expression
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